Skip to main content
Premium Trial:

Request an Annual Quote

Princess Margaret Personalized Medicine Effort Reaps $50M Gift

NEW YORK (GenomeWeb News) – Canada's Princess Margaret Cancer Foundation said today that it will use a new C$50 million (US$50.3 million) private donation to fund a research effort that will use genomics, molecular imaging, and tumor biology studies to develop personalized cancer medicine innovations.

The gift from philanthropists Emmanuelle Gattuso and Allan Slaight will fund the Princess Margaret Cancer Centre's Personalized Cancer Medicine Initiative. The cancer center's research arm is the Ontario Cancer Institute, which includes the Campbell Family Cancer Research Institute.

The new donation will support the foundation's Billion Dollar Challenge, which aims to raise C$1 billion to fund the personalized medicine effort and has netted C$243 million in donations and grants to date.

The Personalized Cancer Medicine Initiative will fund research projects seeking to detect tumors earlier in their progression, analyze them more precisely, and target them with specific interventions.

"This unprecedented "superfund" allows us to build and support research teams focused on precision genomics, advanced tumour biology, immune therapy, and molecular imaging," Benjamin Neel, research director of the Princess Margaret Cancer Centre, said in a statement.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.